Gabriele Madonna
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Dissecting the Spectrum of Rare BRAF Mutations in Melanoma: A Nation-Wide Study by the Italian Melanoma Intergroup (IMI).
Journal: Pigment cell & melanoma research
Published: August 07, 2025
Development of an innovative duplex digital PCR assay for circulating MiRNA ratio quantification in metastatic melanoma.
Journal: Journal of translational medicine
Published: June 24, 2025
Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 25, 2025
Correction to: Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.
Journal: Journal of translational medicine
Published: October 23, 2024
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study).
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 26, 2024
Innate Immune Cells in Melanoma: Implications for Immunotherapy.
Journal: International journal of molecular sciences
Published: July 12, 2024
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma.
Journal: Journal of translational medicine
Published: June 05, 2024
Role of the androgen receptor in melanoma aggressiveness.
Journal: Cell death & disease
Published: April 22, 2024
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.
Journal: EClinicalMedicine
Published: April 04, 2024
Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients.
Journal: Cell host & microbe
Published: October 17, 2023
Last Updated: 09/26/2026